Depletion studies functionally validated the requirement of CD8+ T cells and NK cells—but not neutrophils or monocytes—for LNP/pNC-mediated tumor suppression, underscoring the importance of cytotoxic lymphocytes in driving therapeutic responses (Figure 7). The gene discussed is CD8A; the disease is neoplasm.